Regen BioPharma Inc
(OTCPK:RGBP)
$
0.28
0.07459 (36.31%)
Market Cap: 1.26 Mil
Enterprise Value: 1.58 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 35/100 Regen BioPharma Inc At Emerging Growth Conferenece Transcript
Feb 22, 2023 / 07:40PM GMT
Release Date Price:
$2.85
(-5.00%)
Ana Berry
Berry Media, Inc. - Moderator
Welcome back, everyone. Next up, we have Regen BioPharma Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. Focused on the immunology and immunotherapy space, this company has focused on rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials. Currently, the company has focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Please welcome its President and CEO, David Koos, with Senior Scientific Consultant, Harry Lander. Welcome back, gentlemen.
David Koos
Regen BioPharma, Inc. - CEO, President & Chairman
Well, thank you, Ana, and we're happy to be here and looking forward to addressing any questions and issues that shareholders may have.
Ana Berry
Berry Media, Inc. - Moderator
Right.
Questions & Answers
David Koos
Regen BioPharma, Inc. - CEO, President & Chairman
And with that, I'll start off with no particular order.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot